Treatment of gram-negative bacteremia in patients with cancer and granulocytopenia.
D000380:Agranulocytosis / Q000150:complications*; D000583:Amikacin / Q000008:administration & dosage; D002442:Ceftazidime / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006090:Gram-Negative Bacteria; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D018805:Sepsis / Q000188:drug therapy*
D000583:Amikacin; D002442:Ceftazidime